Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    omega-3 prodromal
Show Display Options
Rank Status Study
1 Active, not recruiting NAPLS Omega-3 Fatty Acid Versus Placebo Study
Condition: Psychosis
Interventions: Drug: Omega-3 Long Chain Fatty Acid;   Drug: Placebo
2 Completed Ethyl-EPA Treatment of Prodromal Patients
Condition: Schizophrenia Prodrome
Intervention: Drug: ethyl-eicosapentaenoic acid
3 Completed Indicated Prevention With Omega-3 Fatty Acids in Adolescents With 'At-Risk-Mental-State' for Psychosis
Conditions: Schizophrenia;   Prodrome
Intervention: Drug: Omega 3 fatty acids

Indicates status has not been verified in more than two years